These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17724005)

  • 21. [The pathomechanism of polycystic ovary syndrome in the light of recent research findings].
    Károlyi Z
    Orv Hetil; 2012 Oct; 153(40):1567-9. PubMed ID: 23022879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
    Rachoń D; Teede H
    Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and the pubertal transition in girls and boys.
    Burt Solorzano CM; McCartney CR
    Reproduction; 2010 Sep; 140(3):399-410. PubMed ID: 20802107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of genetic and environmental factors in the development of polycystic ovary syndrome].
    Ságodi L; Kiss-Tóth E; Barkai L
    Orv Hetil; 2013 Apr; 154(17):650-7. PubMed ID: 23608312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome].
    Amador N; Espinoza G; Guízar JM; González M; Alpízar M
    Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiposity and metabolic dysfunction in polycystic ovary syndrome.
    Sam S
    Horm Mol Biol Clin Investig; 2015 Feb; 21(2):107-16. PubMed ID: 25781555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polycystic ovary syndrome: significance of insulin resistance].
    Grott S; Algenstaedt P
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2261-6. PubMed ID: 14574641
    [No Abstract]   [Full Text] [Related]  

  • 28. Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition.
    Sprung VS; Jones H; Pugh CJ; Aziz NF; Daousi C; Kemp GJ; Green DJ; Cable NT; Cuthbertson DJ
    Clin Sci (Lond); 2014 Jan; 126(1):67-74. PubMed ID: 23826984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on mechanism of polycystic ovary syndrome and the diagnosis and treatment princial for adolescents].
    Gong CX; Li YC; Wu D
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):425-8. PubMed ID: 22931938
    [No Abstract]   [Full Text] [Related]  

  • 32. Polycystic ovary syndrome.
    Nandi A; Chen Z; Patel R; Poretsky L
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):123-47. PubMed ID: 24582095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine abnormalities. Foreword.
    Schapiro NA
    Curr Probl Pediatr Adolesc Health Care; 2013; 43(5):103. PubMed ID: 23582591
    [No Abstract]   [Full Text] [Related]  

  • 34. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome and environmental toxins.
    Rutkowska AZ; Diamanti-Kandarakis E
    Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic heart disease and diabetes type 2.
    Kerem N; Guttmann H; Hochberg Z
    Horm Res; 2001; 55(6):298-304. PubMed ID: 11805435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and insulin resistance in children.
    Tagi VM; Chiarelli F
    Curr Opin Pediatr; 2020 Aug; 32(4):582-588. PubMed ID: 32520824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Eur J Endocrinol; 2014 May; 170(5):727-39. PubMed ID: 24591551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.